<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Emboliform Nucleus Neurons</th>
</tr>
<tr>
<td class="label">Nucleus</td>
<td>Position</td>
</tr>
<tr>
<td class="label">Emboliform</td>
<td>Most lateral</td>
</tr>
<tr>
<td class="label">Globose</td>
<td>Medial to emboliform</td>
</tr>
<tr>
<td class="label">Resting membrane potential</td>
<td>-60 to -70 mV</td>
</tr>
<tr>
<td class="label">Input resistance</td>
<td>50-150 MΩ</td>
</tr>
<tr>
<td class="label">Firing rate (spontaneous)</td>
<td>10-50 Hz</td>
</tr>
<tr>
<td class="label">Action potential duration</td>
<td>0.5-1.0 ms</td>
</tr>
<tr>
<td class="label">Afterhyperpolarization</td>
<td>5-15 mV, 50-100 ms</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Purkinje cells (hemispheric zone)</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Inferior olive</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Reticular formation</td>
<td>Glutamate/GABA</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">AMPA receptor antagonists</td>
<td>Reduce excitation</td>
</tr>
<tr>
<td class="label">Calcium channel modulators</td>
<td>Normalize firing</td>
</tr>
<tr>
<td class="label">GABA agonist
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Emboliform Nucleus Neurons</th>
</tr>
<tr>
<td class="label">Nucleus</td>
<td>Position</td>
</tr>
<tr>
<td class="label">Emboliform</td>
<td>Most lateral</td>
</tr>
<tr>
<td class="label">Globose</td>
<td>Medial to emboliform</td>
</tr>
<tr>
<td class="label">Resting membrane potential</td>
<td>-60 to -70 mV</td>
</tr>
<tr>
<td class="label">Input resistance</td>
<td>50-150 MΩ</td>
</tr>
<tr>
<td class="label">Firing rate (spontaneous)</td>
<td>10-50 Hz</td>
</tr>
<tr>
<td class="label">Action potential duration</td>
<td>0.5-1.0 ms</td>
</tr>
<tr>
<td class="label">Afterhyperpolarization</td>
<td>5-15 mV, 50-100 ms</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Purkinje cells (hemispheric zone)</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Inferior olive</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Reticular formation</td>
<td>Glutamate/GABA</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">AMPA receptor antagonists</td>
<td>Reduce excitation</td>
</tr>
<tr>
<td class="label">Calcium channel modulators</td>
<td>Normalize firing</td>
</tr>
<tr>
<td class="label">GABA agonists</td>
<td>Enhance inhibition</td>
</tr>
<tr>
<td class="label">Antioxidants</td>
<td>Neuroprotection</td>
</tr>
<tr>
<td class="label">Neurotrophic factors</td>
<td>Support neuronal survival</td>
</tr>
</table>
Emboliform Nucleus Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The emboliform nucleus is one of the three nuclei comprising the interposed nuclei of the cerebellum (the others being the globose nuclei). It is the most lateral component of the interposed complex and serves as a major output pathway for the cerebellar hemispheres, particularly involved in forelimb motor control and precision grip movements. The emboliform nucleus receives inhibitory GABAergic input from Purkinje cells of the cerebellar hemispheric zone and sends excitatory glutamatergic projections primarily to the red nucleus and thalamus. In neurodegenerative diseases, the emboliform nucleus is affected in conditions including spinocerebellar ataxias, multiple system atrophy, and Parkinson's disease, contributing to the characteristic limb ataxia, dysmetria, and motor coordination deficits observed in these disorders. [@ruigrok2011]
The emboliform nucleus is located in the roof of the fourth ventricle, situated: [@apps2018]
The emboliform nucleus contains two principal neuronal populations:
Projection Neurons (70-80% of neurons)
Emboliform neurons exhibit:
Emboliform neurons express multiple voltage-gated channels:
The emboliform nucleus integrates multiple synaptic inputs:
The emboliform nucleus projects to:
The emboliform-red nucleus pathway is critical for:
The emboliform nucleus contributes to:
The emboliform nucleus is prominently affected in multiple SCAs:
The study of Emboliform Nucleus Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following diagram shows the key molecular relationships involving Emboliform Nucleus Neurons discovered through SciDEX knowledge graph analysis: